Literature DB >> 19336738

Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.

Sharon Noy-Lotan1, Orly Dgany, Roxane Lahmi, Nathaly Marcoux, Tanya Krasnov, Nissan Yissachar, Doron Ginsberg, Benny Motro, Peretz Resnitzky, Isaac Yaniv, Gary M Kupfer, Hannah Tamary.   

Abstract

BACKGROUND: Congenital dyserythropoietic anemia type I is an inherited autosomal recessive macrocytic anemia associated with ineffective erythropoiesis and the development of secondary hemochromatosis. Distinct erythroid precursors with internuclear chromatin bridges and spongy heterochromatin are pathognomonic for the disease. The mutated gene (CDAN1) encodes a ubiquitously expressed protein of unknown function, codanin-1. Based on the morphological features of congenital dyserythropoietic anemia type I erythroblasts and data on a role in cell cycle progression of codanin-1 homolog in Drosophila we investigated the cellular localization and possible involvement of codanin-1 during the cell cycle. DESIGN AND METHODS: Codanin-1 localization was studied by immunofluorescence and immune electron microscopy. Cell cycle expression of codanin-1 was evaluated using synchronized HeLa cells. E2F proteins are the main regulator of G(1)/S transition. An E2F1-inducible cell line (U20S-ER-E2F1) enabled us to study codanin-1 expression following ectopic E2F1 induction. Direct binding of E2F1 to codanin-1 promoter was assessed by chromatin immunoprecipitation. We used a luciferase-reporter plasmid to study activation of CDAN1 transcription by E2F1.
RESULTS: We localized codanin-1 to heterochromatin in interphase cells. During the cell cycle, high levels of codanin-1 were observed in the S phase. At mitosis, codanin-1 underwent phosphorylation, which coincided with its exclusion from condensed chromosomes. The proximal CDAN1 gene promoter region, containing five putative E2F binding sites, was found to be a direct target of E2F1.
CONCLUSIONS: Taken together, these data suggest that codanin-1 is a cell cycle-regulated protein active in the S phase. The exact role of codanin-1 during the S phase remains to be determined. Nevertheless this represents the first step towards understanding the function of the proteins involved in congenital dyserythropoietic anemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336738      PMCID: PMC2675674          DOI: 10.3324/haematol.2008.003327

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  32 in total

1.  E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis.

Authors:  Shirley Polager; Yael Kalma; Eli Berkovich; Doron Ginsberg
Journal:  Oncogene       Date:  2002-01-17       Impact factor: 9.867

2.  Loss of E2F4 activity leads to abnormal development of multiple cellular lineages.

Authors:  R E Rempel; M T Saenz-Robles; R Storms; S Morham; S Ishida; A Engel; L Jakoi; M F Melhem; J M Pipas; C Smith; J R Nevins
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

Review 3.  The E2F transcription factors: key regulators of cell proliferation.

Authors:  H Müller; K Helin
Journal:  Biochim Biophys Acta       Date:  2000-02-14

Review 4.  Heterochromatin revisited.

Authors:  Shiv I S Grewal; Songtao Jia
Journal:  Nat Rev Genet       Date:  2007-01       Impact factor: 53.242

5.  Mitotic partitioning of transcription factors.

Authors:  Geneviève P Delcuve; Shihua He; James R Davie
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

6.  ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry.

Authors:  Katya Korotayev; Marie Chaussepied; Doron Ginsberg
Journal:  Cell Signal       Date:  2008-02-21       Impact factor: 4.315

7.  Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.

Authors:  F Qiao; A Moss; G M Kupfer
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

8.  E2F4 is essential for normal erythrocyte maturation and neonatal viability.

Authors:  P O Humbert; C Rogers; S Ganiatsas; R L Landsberg; J M Trimarchi; S Dandapani; C Brugnara; S Erdman; M Schrenzel; R T Bronson; J A Lees
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

Review 9.  Congenital dyserythropoietic anemia type III.

Authors:  H Sandström; A Wahlin
Journal:  Haematologica       Date:  2000-07       Impact factor: 9.941

Review 10.  The congenital dyserythropoietic anaemias.

Authors:  J Delaunay; A Iolascon
Journal:  Baillieres Best Pract Res Clin Haematol       Date:  1999-12
View more
  13 in total

1.  Close to unraveling the secrets of congenital dyserythropoietic anemia types I and II.

Authors:  Achille Iolascon; Jean Delaunay
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

2.  Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation.

Authors:  Zachary C Murphy; Michael R Getman; Jaquelyn A Myers; Kimberly N Burgos Villar; Emily Leshen; Ryo Kurita; Yukio Nakamura; Laurie A Steiner
Journal:  Exp Hematol       Date:  2020-10-16       Impact factor: 3.084

3.  Congenital dyserythropoietic anemia.

Authors:  Takahiro Kamiya; Atsushi Manabe
Journal:  Int J Hematol       Date:  2010-09-07       Impact factor: 2.490

Review 4.  The congenital dyserythropoieitic anemias: genetics and pathophysiology.

Authors:  Richard King; Patrick J Gallagher; Rami Khoriaty
Journal:  Curr Opin Hematol       Date:  2021-12-24       Impact factor: 3.218

5.  Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply.

Authors:  Katrine Ask; Zuzana Jasencakova; Patrice Menard; Yunpeng Feng; Geneviève Almouzni; Anja Groth
Journal:  EMBO J       Date:  2012-03-09       Impact factor: 11.598

6.  Characterization of Two Cases of Congenital Dyserythropoietic Anemia Type I Shed Light on the Uncharacterized C15orf41 Protein.

Authors:  Roberta Russo; Roberta Marra; Immacolata Andolfo; Gianluca De Rosa; Barbara Eleni Rosato; Francesco Manna; Antonella Gambale; Maddalena Raia; Sule Unal; Susanna Barella; Achille Iolascon
Journal:  Front Physiol       Date:  2019-05-22       Impact factor: 4.566

Review 7.  The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.

Authors:  Noémi B A Roy; Christian Babbs
Journal:  Br J Haematol       Date:  2019-03-05       Impact factor: 6.998

Review 8.  Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.

Authors:  Achille Iolascon; Hermann Heimpel; Anders Wahlin; Hannah Tamary
Journal:  Blood       Date:  2013-08-12       Impact factor: 22.113

Review 9.  Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

Authors:  Achille Iolascon; Maria Rosaria Esposito; Roberta Russo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

10.  Genetic and functional insights into CDA-I prevalence and pathogenesis.

Authors:  Aude-Anais Olijnik; Noémi B A Roy; Caroline Scott; Joseph A Marsh; Jill Brown; Karin Lauschke; Katrine Ask; Nigel Roberts; Damien J Downes; Sanja Brolih; Errin Johnson; Barbara Xella; Melanie Proven; Ria Hipkiss; Kate Ryan; Per Frisk; Johan Mäkk; Eva-Lena Maria Stattin; Nandini Sadasivam; Louisa McIlwaine; Quentin A Hill; Raffaele Renella; Jim R Hughes; Richard J Gibbons; Anja Groth; Peter J McHugh; Douglas R Higgs; Veronica J Buckle; Christian Babbs
Journal:  J Med Genet       Date:  2020-06-09       Impact factor: 5.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.